In this session talks will be focused on new, more streamlined approaches to analytical method development and transfer for both product release and characterization. Examples would include eliminating some product release assays through more powerful MS methods, using platform analytical methods for speed of development and transfer and other strategies for rapid method development.
Mike Washabaugh, MedImmune
Laura Bass, Pfizer
Rob Dufield, Pfizer: Analytical Strategies Enabling Expedited Development of Therapeutic mAbs
Qinjian Zhao, Xiamen University: Structural and Functional Analysis of Recombinant Virus-like Particles (VLP's)
Kuldip Sra, MedImmune: Development of a Seasonal Vaccine